Literature DB >> 31337672

β8 Integrin Mediates Pancreatic Cancer Cell Radiochemoresistance.

Sha Jin1, Wei-Chun Lee1, Daniela Aust2,3,4, Christian Pilarsky5, Nils Cordes6,4,7,8,9.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) stroma, composed of extracellular matrix (ECM) proteins, promotes therapy resistance and poor survival rate. Integrin-mediated cell/ECM interactions are well known to control cancer cell survival, proliferation, and therapy resistance. Here, we identified β8 integrin in a high-throughput knockdown screen in three-dimensional (3D), ECM-based cell cultures for novel focal adhesion protein targets as a critical determinant of PDAC cell radiochemoresistance. Intriguingly, β8 integrin localizes with the golgi apparatus perinuclearly in PDAC cells and resection specimen from PDAC patients. Upon radiogenic genotoxic injury, β8 integrin shows a microtubule-dependent perinuclear-to-cytoplasmic shift as well as strong changes in its proteomic interactome regarding the cell functions transport, catalysis, and binding. Parts of this interactome link β8 integrin to autophagy, which is diminished in the absence of β8 integrin. Collectively, our data reveal β8 integrin to critically coregulate PDAC cell radiochemoresistance, intracellular vesicle trafficking, and autophagy upon irradiation. IMPLICATIONS: This study identified β8 integrin as an essential determinant of PDAC cell radiochemosensitivity and as a novel potential cancer target. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 31337672     DOI: 10.1158/1541-7786.MCR-18-1352

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  9 in total

Review 1.  αvβ8 integrin adhesion and signaling pathways in development, physiology and disease.

Authors:  Joseph H McCarty
Journal:  J Cell Sci       Date:  2020-06-15       Impact factor: 5.285

Review 2.  Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma.

Authors:  Vida Karimnia; Frank J Slack; Jonathan P Celli
Journal:  Cancers (Basel)       Date:  2021-08-28       Impact factor: 6.575

3.  Paradoxical role of β8 integrin on angiogenesis and vasculogenic mimicry in glioblastoma.

Authors:  Yang Liu; Xiangdong Xu; Yuxuan Zhang; Yunzhao Mo; Xinlin Sun; Lingling Shu; Yiquan Ke
Journal:  Cell Death Dis       Date:  2022-06-08       Impact factor: 9.685

Review 4.  Targeting Integrins in Cancer Nanomedicine: Applications in Cancer Diagnosis and Therapy.

Authors:  Ping-Hsiu Wu; Abayomi Emmanuel Opadele; Yasuhito Onodera; Jin-Min Nam
Journal:  Cancers (Basel)       Date:  2019-11-13       Impact factor: 6.639

Review 5.  Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics.

Authors:  Sophia G Kisling; Gopalakrishnan Natarajan; Ramesh Pothuraju; Ashu Shah; Surinder K Batra; Sukhwinder Kaur
Journal:  Cancer Metastasis Rev       Date:  2021-09-30       Impact factor: 9.264

Review 6.  Integrin β1 in Pancreatic Cancer: Expressions, Functions, and Clinical Implications.

Authors:  Jiajia Li; Liyao Peng; Qun Chen; Ziping Ye; Tiantian Zhao; Sicong Hou; Jianguo Gu; Qinglei Hang
Journal:  Cancers (Basel)       Date:  2022-07-11       Impact factor: 6.575

7.  Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancreatic Cancer Cultures.

Authors:  Josephine Görte; Elke Beyreuther; Erik H J Danen; Nils Cordes
Journal:  Cancers (Basel)       Date:  2020-10-31       Impact factor: 6.639

8.  CRISPR-Cas9 Screen Identifies DYRK1A as a Target for Radiotherapy Sensitization in Pancreatic Cancer.

Authors:  Bin Lan; Siyuan Zeng; Shuman Zhang; Xiaofan Ren; Yuming Xing; Isabella Kutschick; Susanne Pfeffer; Benjamin Frey; Nathalie Britzen-Laurent; Robert Grützmann; Nils Cordes; Christian Pilarsky
Journal:  Cancers (Basel)       Date:  2022-01-10       Impact factor: 6.639

9.  Baicalein Inhibits Metastatic Phenotypes in Nasopharyngeal Carcinoma Cells via a Focal Adhesion Protein Integrin β8.

Authors:  Pichamon Kiatwuthinon; Thana Narkthong; Utapin Ngaokrajang; Supeecha Kumkate; Tavan Janvilisri
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.